Diagnostic accuracy of the Copenhagen Index in ovarian malignancy: A meta-analysis
Authors:
Open Access
- 14 June 2023
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (6) , e0286650
Abstract
Objective: To assess the diagnostic value of the Copenhagen index for ovarian malignancy. Methods: PubMed, Web of Science, the Cochrane Library, Embase, CBM, CNKI, and WanFang databases were searched throughout June 2021. Statistical analyses were performed using Stata 12, Meta-DiSc, and RevMan 5.3. The pooled sensitivity, specificity, and diagnostic odds ratio were calculated, the summary receiver operating characteristic curve was drawn, and the area under the curve was calculated. Results: Ten articles, including 11 studies with a total of 5266 patients, were included. The pooled sensitivity, specificity, and diagnostic odds ratio were 0.82 [95% CI (0.80–0.83)], 0.88 [95% CI (0.87–0.89)], and 57.31 [95% CI (32.84–100.02)], respectively. The area under the summary receiver operating characteristics curve and the Q index were 0.9545 and 0.8966, respectively. Conclusion: Our systematic review shows that the sensitivity and specificity of the Copenhagen index are high enough for it to be used in a clinical setting to provide accurate ovarian cancer diagnosis without considering menopausal status.Keywords
Funding Information
- National Natural Science Foundation of China (82260557)
This publication has 26 references indexed in Scilit:
- Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disordersAmerican Journal of Obstetrics and Gynecology, 2012
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Committee Opinion No. 477: The Role of the Obstetrician–Gynecologist in the Early Detection of Epithelial Ovarian CancerObstetrics & Gynecology, 2011
- SGO White Paper on Ovarian Cancer: Etiology, Screening and SurveillanceGynecologic Oncology, 2010
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic massGynecologic Oncology, 2009
- The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic massGynecologic Oncology, 2008
- The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessedJournal of Clinical Epidemiology, 2005
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- A Major Human Epididymis-Specific cDNA Encodes a Protein with Sequence Homology to Extracellular Proteinase Inhibitors1Biology of Reproduction, 1991
- A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancerBJOG: An International Journal of Obstetrics & Gynaecology, 1990